Chronic pelvic and testicular pain

What is chronic prostatitis/chronic pelvic pain syndrome?

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) generally refers to pelvic pain or discomfort lasting at least three months, often with urinary or sexual symptoms, when persistent bacterial infection does not adequately explain the condition.⁴

Symptoms may include:

• perineal pain;
• penile pain;
• discomfort at the base of the penis;
• suprapubic pain;
• pain after ejaculation;
• urinary urgency or frequency;
• weak or uncomfortable urination;
• testicular or groin pain;
• sexual dysfunction.

The symptom pattern can vary substantially between patients.

Is CP/CPPS the same as chronic bacterial prostatitis?

No—and this is one of the most important distinctions in the whole topic.

Chronic bacterial prostatitis is a genuine persistent bacterial infection of the prostate. It often presents with recurrent UTIs caused by the same organism and is treated with antibiotics that penetrate prostate tissue.⁴

CP/CPPS is different. Infection is not established as the continuing cause, and repeated antibiotics may therefore provide little or no benefit for many patients.

A 2025 JAMA review explicitly separates acute bacterial prostatitis, chronic bacterial prostatitis and CP/CPPS as distinct diagnostic and treatment problems.⁴

Why can pain persist after infection or injury has gone?

Pain is not only a direct read-out of current tissue damage.

Persistent pain can involve:

• sensitised peripheral nerves;
• altered spinal or central pain processing;
• pelvic-floor muscle overactivity;
• myofascial trigger points;
• urinary urgency or obstruction;
• previous infection or inflammation;
• stress-related amplification of pain pathways;
• sleep disturbance;
• sexual pain and avoidance.

The 2025 AUA evaluation guideline emphasises that men with chronic pelvic pain may have symptoms and contributing conditions beyond the urinary tract and that evaluation needs to reflect this broader biology.¹

Does that mean chronic pelvic pain is psychological?

No.

A biopsychosocial model does not mean “the pain is in your head”. It means biological, neurological, muscular, emotional and social factors can interact to determine how persistent pain is experienced.

For example, a patient may have genuine pelvic-floor muscle tenderness, sensitised nerves and poor sleep. Anxiety about the pain may then increase muscle guarding and threat perception, which can make the pain harder to settle.

Treating the nervous system or psychological consequences of chronic pain is therefore not a denial of physical symptoms; it can be part of treating the condition itself.

What should be checked before calling it chronic pelvic pain syndrome?

The purpose of assessment is to look for other treatable or important causes.

Depending on the history, evaluation may include:

• urine testing and culture;
• examination of the abdomen and genitalia;
• prostate examination when appropriate;
• assessment of pelvic-floor tenderness;
• measurement of residual urine;
• investigation for stones or obstruction;
• imaging when there is a specific indication;
• sexual and bowel symptom review.

The AUA guideline stresses the heterogeneity of presentation and the need to assess associated conditions rather than relying on a narrow prostate-only model.¹

How weak is the evidence, exactly?

Worth stating numerically, because it explains a great deal of what patients experience.

A Cochrane review pooled 99 randomised trials and 9,119 men across sixteen drug treatments for chronic prostatitis and chronic pelvic pain. Its verdict on almost everything examined was low to very low certainty, with small trials, short follow-up averaging around twelve weeks, and sparse reporting of sexual function, quality of life and mental health.

That is not a reason to do nothing. It is the reason a single confident recommendation should make you suspicious, and why the honest plan is usually several things tried in a deliberate order.

What treatments actually work for CP/CPPS?

There is no single treatment with reliable benefit for every patient.

The 2025 AUA treatment guideline recommends a multimodal and multidisciplinary approach, which may include lifestyle measures, behavioural therapy, medication, pelvic-health treatment and selected procedures.²

The key is to match treatment to the patient's dominant features.

What about alpha-blockers?

Alpha-blockers relax smooth muscle at the prostate and bladder outlet. They are most relevant when urinary symptoms are an important part of the syndrome.

The 2025 JAMA review reports trial effects on the NIH Chronic Prostatitis Symptom Index (NIH-CPSI)—a 43-point symptom scale. A reduction of about six points is generally considered clinically meaningful.⁴

In selected CP/CPPS trials involving men with urinary symptoms, alpha-blockers produced improvements versus placebo of roughly 4.8 to 10.8 NIH-CPSI points.⁴

That range should not be treated as a guaranteed effect. Trial populations differ, and benefit is most plausible in men whose symptom phenotype includes voiding dysfunction.

What about anti-inflammatory or nerve-pain medication?

The same review found more modest average improvements with several non-antibiotic medicines.⁴ Reported differences versus placebo included approximately:

• 1.7–2.5 points for anti-inflammatory treatment;
• about 2.4 points for pregabalin;
• around 2.5 points for pollen extract in the trials reviewed.⁴

These average effects are smaller than the roughly six-point threshold often regarded as clinically meaningful on the NIH-CPSI, although individual responses can differ.⁴

This illustrates the problem with seeking a universal “best tablet”.

What about antibiotics?

Antibiotics are essential when bacterial prostatitis is present.⁴

For non-bacterial CP/CPPS, however, repeated antibiotic treatment is much harder to justify once infection has been appropriately assessed and not demonstrated. Some patients may have had an initial infectious trigger, but persistent pain does not necessarily mean persistent bacteria.

The modern emphasis is to stop equating the word “prostatitis” with an automatic need for repeated antibiotics.^{2, 4}

Does pelvic-floor physiotherapy help?

Pelvic-floor physical therapy is an important component of contemporary multimodal care, especially when examination suggests pelvic-floor tenderness, muscle overactivity or myofascial pain.²

The evidence is not as extensive as we would like, and treatment needs to be delivered by clinicians experienced in male pelvic pain. The aim is not generic strengthening. In many patients, the problem may be excessive tension rather than weakness.

What is chronic scrotal content pain?

Chronic scrotal content pain (CSCP) generally means pain localised to structures such as the testis, epididymis or spermatic cord that persists for at least three months and interferes with daily life.

Possible causes include:

• previous infection;
• prior vasectomy;
• hernia surgery;
• varicocele;
• nerve injury;
• pelvic-floor dysfunction;
• referred pain from the spine or pelvis;
• no clearly identifiable cause.

How good is the evidence for chronic testicular pain treatment?

This is where honesty is particularly important.

The 2025 AUA guideline on chronic scrotal content pain states that specific data are limited and that many treatments are based on off-label use or evolving evidence.³

Conservative treatment is usually tried first. Selected patients with very localised pain may later be considered for procedures such as diagnostic nerve blocks or microsurgical denervation, but published success rates often come from selected specialist-centre series rather than large randomised trials.

A procedure can therefore be promising without being predictable.

Will a normal ultrasound mean nothing is wrong?

No. Ultrasound is useful for structural problems such as testicular lesions, hydroceles, varicoceles or some inflammatory changes. But chronic neuropathic or pelvic-floor pain may occur with normal imaging.

A normal scan can be reassuring about certain structural conditions without invalidating the pain itself.

How quickly does chronic pelvic pain improve?

There is no reliable universal timeline.

Because several mechanisms may coexist, improvement is often gradual and may require more than one intervention. The realistic goal may be substantial reduction in pain and return to normal activity rather than an immediate switch from severe symptoms to zero pain.

Expectations matter because repeated changes of treatment after only a few days can make it impossible to judge which intervention is helping.

When should testicular pain be treated as an emergency instead?

Sudden severe testicular pain is not chronic scrotal pain.

Acute severe pain, especially with nausea or a high-riding testis, may indicate testicular torsion and requires urgent assessment. Similarly, a new hard testicular lump, acute swelling with fever or severe systemic illness needs prompt review.

How strong is the evidence?

The AUA guideline series is informed by systematic literature review but includes consensus-based recommendations because high-quality trials are limited.[1–3]

The JAMA review provides useful quantitative estimates for several medications, but these are not equally applicable to every phenotype.⁴

The most important evidence-based conclusion is therefore not that one therapy is superior. It is that chronic pelvic pain is heterogeneous and treatment should be individualised rather than repeatedly applying a single diagnosis and single treatment.^{1, 2}

Bottom line

Chronic pelvic and testicular pain are genuine, high-impact conditions with a weaker evidence base than many other urological diseases.

The strongest modern approach is:

1. exclude important structural, infectious and obstructive causes;
2. distinguish bacterial prostatitis from non-bacterial CP/CPPS;
3. identify the dominant pain and urinary features;
4. use multimodal treatment rather than relying on one repeated therapy;
5. be honest about where the evidence remains uncertain.

There is no single “magic prostatitis treatment”. But there is a much better approach than assuming persistent pain must equal persistent infection.

This is the condition where I am least able to promise you an outcome, and I would rather say that at the first appointment than at the fourth. What I can promise is that I will not simply hand you another course of antibiotics for a problem that is not bacterial, that I will look properly for the things that are treatable, and that we will change one thing at a time so we can tell what is working.